PT92041A - Processo para a preparacao de derivados de acido o-(3-amino-2-hidroxipropil)-hidroximico e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de acido o-(3-amino-2-hidroxipropil)-hidroximico e de composicoes farmaceuticas que os contem

Info

Publication number
PT92041A
PT92041A PT92041A PT9204189A PT92041A PT 92041 A PT92041 A PT 92041A PT 92041 A PT92041 A PT 92041A PT 9204189 A PT9204189 A PT 9204189A PT 92041 A PT92041 A PT 92041A
Authority
PT
Portugal
Prior art keywords
hydroxypropyl
amino
pharmaceutical compounds
derivatives containing
compounds derivatives
Prior art date
Application number
PT92041A
Other languages
English (en)
Other versions
PT92041B (pt
Inventor
Nagy Peter Literati
Bela Balazs
Maria Boross
Jenoe Szilbereky
Gizella Zsila
Lajos Abraham
Gyoergy Blasko
Bela Gachalyi
Attila Almasi
Gabor Nemeth
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of PT92041A publication Critical patent/PT92041A/pt
Publication of PT92041B publication Critical patent/PT92041B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT92041A 1988-10-20 1989-10-19 Processo para a preparacao de derivados de acido o-(3-amino-2-hidroxipropil)-hidroximico e de composicoes farmaceuticas que os contem PT92041B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU885405A HU207988B (en) 1988-10-20 1988-10-20 Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components

Publications (2)

Publication Number Publication Date
PT92041A true PT92041A (pt) 1990-04-30
PT92041B PT92041B (pt) 1995-07-18

Family

ID=10970243

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92041A PT92041B (pt) 1988-10-20 1989-10-19 Processo para a preparacao de derivados de acido o-(3-amino-2-hidroxipropil)-hidroximico e de composicoes farmaceuticas que os contem

Country Status (20)

Country Link
US (3) US5147879A (pt)
EP (1) EP0417210B1 (pt)
JP (1) JPH0819078B2 (pt)
KR (1) KR0154117B1 (pt)
AU (1) AU620460B2 (pt)
CA (1) CA2000830C (pt)
DE (1) DE68913737T2 (pt)
DK (1) DK175584B1 (pt)
ES (1) ES2020030A6 (pt)
FI (1) FI93214C (pt)
GR (1) GR1002253B (pt)
HU (1) HU207988B (pt)
IE (1) IE65113B1 (pt)
IL (1) IL92000A (pt)
NO (1) NO178148C (pt)
PL (1) PL164547B1 (pt)
PT (1) PT92041B (pt)
RU (1) RU2093508C1 (pt)
UA (1) UA34412C2 (pt)
WO (1) WO1990004584A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288824B6 (cs) * 1994-05-06 2001-09-12 Biorex Kutató És Fejlesztö Rt. Deriváty hydroximové kyseliny, farmaceutické prostředky, které je obsahují, způsob jejich přípravy a meziprodukty v tomto způsobu
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78138A (hu) 1995-12-22 2000-09-28 BIOREX Kutató és Fejlesztő Rt Hidroximsavszármazékot tartalmazó készítmény a növénytermesztés elősegítésére és alkalmazása
US6458371B1 (en) 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
US6884424B2 (en) 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
AU745987B2 (en) * 1995-12-22 2002-04-11 N-Gene Research Laboratories Inc. A cosmetic composition and a method for reducing the ageing processes of skin
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
DE19607960A1 (de) * 1996-03-01 1997-09-04 Hoechst Schering Agrevo Gmbh Verfahren zur Herstellung von Ketonoximether durch Boronsäurekupplung
GB9613339D0 (en) * 1996-06-26 1996-08-28 Kritzinger Ann C Limp bookbinding assembly technique for two books in one pass
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
HU220971B1 (hu) * 1997-04-03 2002-07-29 BIOREX Kutató és Fejlesztő Rt. Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
AU5296799A (en) * 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
US6933104B1 (en) 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
CA2682251A1 (en) * 2001-07-17 2003-01-30 N-Gene Research Laboratories Inc. A synergistic pharmaceutical combination for the prevention or treatment of diabetes
HUP0105205A2 (hu) * 2001-11-29 2003-08-28 BIOREX Kutató és Fejlesztő Rt. Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény
ATE384554T1 (de) * 2001-12-21 2008-02-15 Rhodia Kombinierte stabile kationische und anionische tensidzusammensetzungen
RU2320330C2 (ru) 2002-01-11 2008-03-27 СиУайТиАрЭкс КОРПОРЕЙШН Производные карбоксамидина и их использование при лечении заболеваний сосудов
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
US7763601B2 (en) * 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
EP2356988A4 (en) 2008-11-18 2012-05-09 Santen Pharmaceutical Co Ltd THERAPEUTIC FOR CHORIORETINAL DEGENERATION WITH PYRIDINE-3-CARBALDEHYDE O- (PIPERIDIN-1-YL-PROPYL) OXIM DERIVATIVE AS ACTIVE SUBSTANCE
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
AU2018337761C1 (en) 2017-09-22 2025-01-30 Adelaide university Methods and products for improving sperm quality
KR101995300B1 (ko) 2018-03-30 2019-10-17 주식회사 아세아텍 다목적 관리기용 작업기 탈부착장치
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
CN112174853B (zh) * 2020-11-03 2023-07-25 湖南经世新材料有限责任公司 一种氨解法制备（z）-n-羟基苯脒的方法
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
US20240383853A1 (en) * 2021-09-28 2024-11-21 Zevra Denmark A/S Oximes and their use in treatment of gba-related diseases
WO2025014519A1 (en) 2023-07-10 2025-01-16 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes

Also Published As

Publication number Publication date
KR0154117B1 (ko) 1998-12-01
EP0417210B1 (en) 1994-03-09
JPH03502931A (ja) 1991-07-04
NO178148B (no) 1995-10-23
DE68913737D1 (de) 1994-04-14
EP0417210A1 (en) 1991-03-20
AU620460B2 (en) 1992-02-20
FI93214C (fi) 1995-03-10
KR900701741A (ko) 1990-12-04
FI903075A0 (fi) 1990-06-19
ES2020030A6 (es) 1991-07-16
FI93214B (fi) 1994-11-30
US5328906A (en) 1994-07-12
DK175584B1 (da) 2004-12-13
IL92000A0 (en) 1990-07-12
US5147879A (en) 1992-09-15
IE893364L (en) 1990-04-20
DE68913737T2 (de) 1994-07-28
IL92000A (en) 1994-06-24
RU2093508C1 (ru) 1997-10-20
PT92041B (pt) 1995-07-18
CA2000830C (en) 1997-09-16
US5296606A (en) 1994-03-22
NO902703L (no) 1990-06-18
CA2000830A1 (en) 1990-04-20
GR890100669A (el) 1990-11-29
JPH0819078B2 (ja) 1996-02-28
IE65113B1 (en) 1995-10-04
HU207988B (en) 1993-07-28
GR1002253B (en) 1996-04-23
DK149790D0 (da) 1990-06-19
NO178148C (no) 1996-01-31
WO1990004584A1 (en) 1990-05-03
DK149790A (da) 1990-06-19
NO902703D0 (no) 1990-06-18
HUT54110A (en) 1991-01-28
UA34412C2 (uk) 2001-03-15
AU4418689A (en) 1990-05-14
PL164547B1 (pl) 1994-08-31

Similar Documents

Publication Publication Date Title
PT92041A (pt) Processo para a preparacao de derivados de acido o-(3-amino-2-hidroxipropil)-hidroximico e de composicoes farmaceuticas que os contem
PT82591B (pt) Processo para a preparacao de derivados do acido ascorbico e de composicoes farmaceuticas que os contem
PT90836A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT82226B (pt) Processo para a preparacao de 3-ariluracilos e de composicoes herbicidas que os contem
PT89899A (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT89009A (pt) Processo para a preparacao de novos derivados de fluorocitidina e composicoes farmaceuticas que os contem
PT91968A (pt) Processo para a preparacao de novos piperidinil-benzimidazois e de composicoes farmaceuticas que os contem
PT82030B (pt) Processo para a preparacao de derivados de androstenodiona substituidos na posicao 4 e de composicoes farmaceuticas que os contem
PT84319B (pt) Processo para a preparacao de derivados substituidos de tienoimidazol e de composicoes farmaceuticas que os contem
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
PT83355B (pt) Processo para a preparacao de derivados de benzimidazole e de composicoes farmaceuticas que os contem
PT82984B (pt) Processo para a preparacao de derivados de poli-4-aminopirrole-2-carboxamido e de composicoes farmaceuticas que os contem
PT88679A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT83604B (pt) Processo para a preparacao de derivados da flavona e de composicoes farmaceuticas que os contem
PT84023B (pt) Processo para a preparacao de novos derivados da 1-benzeno-sulfonil-2-oxo-alcoxi-pirrolidina e de composicoes farmaceuticas que os contem
PT83565B (pt) Processo para a preparacao de derivados do acido aril-heterociclil-alcoxi-acetico e de composicoes farmaceuticas que os contem
PT91122A (pt) Processo para a preparacao de novos derivados amidinicos e guanidinicos e de composicoes farmaceuticas que os contem
PT83239B (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT82440B (pt) Processo para a preparacao de eteres ciclopentilicos e de composicoes farmaceuticas que os contem
PT82399B (pt) Processo para a preparacao de derivados de fenetanolamina e de composicoes farmaceuticas que os contem
PT83593B (pt) Processo para a preparacao de 7-acil-benzoxazinonas e seus derivados e de composicoes farmaceuticas que os contem
PT90904A (pt) Processo para a preparacao de derivados de 3-oxo-propanonitrilo triciclicos e de composicoes farmaceuticas que os contem
PT89614A (pt) Processo para a preparacao de derivados dos acidos quinolonoe naftiridono-carboxilicos e de composicoes antibacterianas que os contem
PT84565B (pt) Processo para a preparacao de derivados de acido 4-amino-3-hidroxi-butirico substituidos e de composicoes farmaceuticas que os contem
PT87090A (pt) Processo para a preparacao de derivados de imidazopiridinas e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
PD3A Change of proprietorship

Owner name: BIOREX KUTATO ES FEJLESZTO RESZVENYTARSASAG

Effective date: 19990108

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090916

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20100316